Company: SGBAF
Filing Date: 2025-04-01
Form Type: DRS/A
Source: 0000950123-25-003272
Chunk: 340

Company: SES S.A.
Filing Date: 2025-04-01
Form: DRS/A
Chunk 340
---
 deferred income recognized by the Group:

| € million                          
 Balance as of January 1, 2024      |     | Non-current | 337 |   |     | Current |    224 |   |
|:-----------------------------------|:----|:------------|----:|:--|:----|:--------|-------:|:--|
| Revenue recognized during the year |     |             |   — |   |     |         | (1,884 | ) |
| New billings                       |     |             |   — |   |     |         |  1,810 |   |
| Other movements*                   |     |             | (12 | ) |     |         |     70 |   |
| Impact of currency translation     |     |             |  13 |   |     |         |      5 |   |
| Balance as of December 31, 2024    |     |             | 338 |   |     |         |    225 |   |

| * | Other movements include reclassifications (between current and           
 non-current, upfront and deferred, as well as against trade receivables) |

| € million                          
 Balance as of January 1, 2023      |     | Non-current | 359 |   |     | Current |    189 |   |
|:-----------------------------------|:----|:------------|----:|:--|:----|:--------|-------:|:--|
| Revenue recognized during the year |     |             |   — |   |     |         | (1,609 | ) |
| New billings                       |     |             |   — |   |     |         |  1,671 |   |
| Other movements*                   |     |             | (15 | ) |     |         |    (26 | ) |
| Impact of currency translation     |     |             |  (7 | ) |     |         |     (1 | ) |
| Balance as of December 31, 2023    |     |             | 337 |   |     |         |    224 |   |

| * | Other movements include reclassifications (between current and           
 non-current, upfront and deferred, as well as against trade receivables) |

F-63

Confidential Treatment Requested by SES Pursuant to 17 C.F.R. Section 200.83 Consolidated financial statements as of and for the years ended December